Predicting Positive Margins in Resection of Cutaneous Melanoma of the Head and Neck

Size: px
Start display at page:

Download "Predicting Positive Margins in Resection of Cutaneous Melanoma of the Head and Neck"

Transcription

1 The Laryngoscope VC 2013 The American Laryngological, Rhinological and Otological Society, Inc. Predicting Positive Margins in Resection of Cutaneous Melanoma of the Head and Neck J. Jared Christophel, MD, MPH; Andrew K. Johnson, BS; Timothy L. McMurry, PhD; Stephen S. Park, MD; Paul A. Levine, MD Objectives/Hypothesis: Head and neck melanoma surgeons must achieve negative margins before performing margin compromising reconstructions such as a local flap closure. This often necessitates staged operations, including further margin resection. Peripheral sampling is often used before definitive resection to help guide the extent of the resection. If melanoma margin status could be predicted based on lesion characteristics, the surgeon could be more confident in performing definitive closure immediately after resection of some lesions or confident in the need to take larger margins in predictably extensive lesions. Study Design: Retrospective review and logistic regression analysis. Methods: Institutional review board approval was obtained. Out of 637 patients treated for head and neck melanoma by the Department of Otolaryngology Head and Neck Surgery in the last 10 years, 409 patients had primary resection with available histopathologic margin status used as the outcome variable. Predictor variables of demographics, lesion size, pathologic subtype, location on face, and depth of invasion were collected. Results: Histopathologic margin status could be predicted by age but not by the other predictor variables. Conclusions: In this large series of head and neck melanomas excised using National Comprehensive Cancer Network recommended margins, histopathologic margin status could be predicted based on age but not on lesion characteristics. This finding is surprising given the published data showing that melanoma in situ has a higher rate of positive margin compared to subtypes of invasive melanoma. It reinforces the need for delaying reconstruction until margins are clear or performing reconstruction at a time of resection that does not compromise the ability to resect margins further (e.g., skin graft). Key Words: Melanoma, head and neck, cutaneous melanoma, margins, reconstruction. Level of Evidence: 2c. Laryngoscope, 123: , 2013 INTRODUCTION The incidence of cutaneous melanoma has been increasing over the past three decades and was most recently reported at 20.8 cases per 100,000 people. 1 Of these lesions, 25% to 35% present on the head and neck region as the primary site. 2 Although various immunotherapy modalities have been developed in the past decade, the gold standard treatment for all primary cutaneous melanomas continues to be surgical. 3 5 The current National Comprehensive Cancer Network (NCCN) surgical margin guidelines for initial definitive excision of cutaneous melanoma are shown in Table I. 3 From the Department of Otolaryngology Head and Neck Surgery (J.J.C., S.S.P., P.A.L.) and the Department of Health Evaluation Sciences (J.J.C., T.L.M.), University of Virginia Health System, Charlottesville, the University of Virginia School of Medicine (A.K.J.), Charlottesville, Virginia, U.S.A. Editor s Note: This Manuscript was accepted for publication September 24, Presented at the Triological Society Annual Meeting at COSM, San Diego, California, U.S.A., April 18 22, The authors have no funding, financial relationships, or conflicts of interest to disclose. Send correspondence to J. Jared Christophel, MD, Department of Otolaryngology Head and Neck Surgery, University of Virginia Health System, PO Box , Charlottesville, VA jjc3y@virginia.edu DOI: /lary Although these margins are often readily achieved on the trunk and closed primarily, similar resections on the head and neck are more difficult due to anatomic constraints. Fear of disfigurement or loss of function of critical structures may lead the surgeon to take more narrow margins, resulting in incomplete excision. 6 Involved margins may leave residual tumor cells in the wound and incur a higher likelihood of locoregional recurrence or metastasis. 7 Common practice has evolved to delay reconstruction of the excisional defect until negative margins are confirmed with histopathologic staining. This requires a second surgery and maintenance of a large wound in the interim. In addition, the 0.5-cm margin recommended for melanoma in situ (MIS) leaves 14% to 50% of patients with positive margins requiring re-excision Some centers have used peripheral sampling techniques for MIS or large melanomas to ensure clear margins before definitive excision, and others have used the Mohs technique. 9,11,12 Even with peripheral sampling, many surgeons will still delay reconstruction (meaning 3 surgeries) until final pathology review of the primary specimen because finding a melanoma within an MIS (up to 12%) or a deeper melanoma than originally biopsied may require wider excision or nodal biopsies. 6,10 Although more widely accepted, the delayed reconstruction approach incurs significant morbidity in patients, 683

2 TABLE I. Principles of Surgical Margins for Wide Excision of Primary Melanoma. Tumor Thickness, mm Recommended Clinical Margins, cm In situ >4 2.0 National Comprehensive Cancer Network Melanoma Guidelines and some centers utilize immediate reconstruction in selected cases. 13,14 There are minimal survival data available for this technique, although the positive margin rate and local recurrence rate in these selected cases remains low. 15 The objective of our study was to define a set of predictive factors for a positive histopathologic margin for melanoma of the head and neck when following NCCN surgical margin guidelines. This information could help surgeons determine which reconstructions could possibly be performed immediately. MATERIALS AND METHODS Study Design Retrospective review and logistic regression analysis. Approval was obtained from the University of Virginia Institutional Review Board for Health Sciences Research. All patients who underwent surgery for cutaneous melanoma at the University of Virginia Department of Otolaryngology Head and Neck Surgery (UVA OTO-HNS) between February 2001 and June 2011 were included in a data set and analyzed for factors predictive of positive histopathologic margin after primary resection. Patients. A total of 637 patients were identified from the Clinical Data Repository at the University of Virginia who had a cutaneous melanoma resected by surgeons at the UVA OTO- HNS. After we excluded patients for whom the pathology report was unavailable, primary definitive excision was performed elsewhere, or cutaneous excision was performed for reason other than primary resection (recurrence or cutaneous metastasis), 412 patients remained. Surgical Resection Surgical margins depended on the depth of invasion (DOI), with margins taken according to NCCN guidelines, which have remained constant over the time period studied (Table I). 3,16 20 Surgical margin was recorded from operative reports when available. In a small subset of patients (n ¼ 8), the recommended margins could not be achieved because of anatomic constraints (e.g., nasal ala or eyelid). Statistical Analysis Hypothesis. We hypothesized that positive histopathologic margin is predictable based on patient and lesion characteristics. Predictor variables. Variables hypothesized to correlate with histopathologic margin status included age, pathologic subtype, location on face, DOI, and lesion diameter. These data were collected from patient charts and recorded as missing if unavailable. Outcome variable. Histopathologic margin was used as the dependent variable and was determined from the pathology report. A histopathologic margin was considered positive if tumor was present <1.0 mm from the edge of the specimen. Logistic regression. The data consisted of 412 subjects, three of whom were missing pathologic margin data, leaving 409 subjects for analysis. The data were randomly split into a training data set of 300 and a test set of 109. The variables considered as possible predictors of positive margin were an indicator for MIS, DOI, an indicator for tumor on the scalp, log size of lesion, and age on the date of surgery. The predictors were individually screened for significance on the training data set using logistic regression, except that the MIS indicator and DOI were combined for the initial screening. R version (R Foundation for Statistical Computing, Vienna, Austria. ISBN ; was used to perform the logistic regression and formulate the receiver operating characteristic (ROC) curve. RESULTS Descriptive Statistics and Frequencies Table II summarizes the data set by margin status stratified according to the nominal variables of melanoma subtype and location on the head and neck. Table III summarizes margin status by the scale variables of DOI, lesion size, and patient age. Table IV summarizes margin status by the ordinal variables of tumor stage and clinically relevant lesion size. MIS was the most common type of melanoma resected, followed by lentiginous melanoma. The cheek is the most common location treated followed by ear and then scalp. T1 is the most common invasive tumor stage treated, with frequency decreasing as tumor stage increases. TABLE II. Margin Status by Nominal Variables (Subtype and Subsite). Frequency (þ) Margin (%) Subtype MIS (12) Lentiginous (16) SS 66 6 (9) Nodular 17 1 (6) Amelanotic 3 2 (67) NOS 92 4 (4) Spindle 21 5 (24) Subsite Nose 39 6 (15) Eyelid 12 2 (17) Cheek (14) Ear 79 5 (6) Neck 52 5 (10) Forehead 27 5 (19) Lips 2 0 (0) Temple 25 3 (12) Scalp 67 7 (10) MIS ¼ melanoma in situ; NOS ¼ not otherwise specified; SS ¼ superficial spreading. 684

3 TABLE III. Margin Status by Scale Variables (Depth of Invasion and Age). Mean DOI, mm 1.89 * 1.89 Size, mm Age, yr *Includes only invasive melanoma subtypes (melanoma in situ excluded). DOI ¼ depth of invasion; SD ¼ standard deviation. SD These descriptive characteristics of the data set were important to confirm, showing that the data comprise a representative sample similar to what is treated elsewhere in terms of tumor type, tumor size, and patient demographics. 10,13 TABLE IV. Margin Status by Ordinal Variables (Tumor Stage, Lesion Size). Frequency (þ) Margin (%) Tumor stage Tis (12) T (13) T (10) T (12) T (9) Missing 4 1 (25) Lesion size, mm (17) (12) (17) > (11) Missing (3) Fig. 1. Receiver operating curve (ROC) for logistical model fit to entire data set. Predicting Positive Histopathologic Margin Of the individual predictors listed here that were screened on the training data set, only age was statistically significant (P ¼.0166 on the training set). We then attempted to assess how well a model relying on age is able to predict a positive margin. Using a logistic model containing only age, the area under the ROC curve was on the training data set, and when tested on the held-out test data set, gave an area under the ROC curve of 0.555, suggesting that age has a positive but limited predictive power. A final logistic model was then refit on the entire data set, resulting in the model: Ln odds of positive margin ¼ þ [Age at Surgery], where the age coefficient in the final model is significant at P ¼ Using this model on the entire data set, the area under the ROC curve was (Fig. 1). To illustrate the changing likelihood of positive margin with age, we split the data into approximate quartiles by age and looked at the percentage positive histopathologic margins in each quartile. (Note: one patient s age was missing, so this record was excluded.) The percentages of positive margins are given in Table V. DISCUSSION This data set provided a large number of patients for an outcomes study. An infrequent outcome variable requires a large data set to reliably study multiple predictor variables. The outcome variable positive histopathologic margin after resection of cutaneous melanoma has been reported to be between 6% and 24% in other studies. 10,13 The overall positive histopathologic margin rate in this study was 11.7% (48 of 412) for all tumors treated. A formal power analysis was not performed because in the case of multiple logistic regression, the power depends strongly on the relationship between individual predictors, which is not possible to meaningfully estimate in advance. There is a statistical rule of thumb that recommends 10 events per predictor of interest. 21 With almost 50 outcomes of interest, it allowed us to reliably investigate five predictor variables. We further attempted to ensure reliable results by first randomly splitting the data into training and test sets, estimating effects on the training set only, and then confirming the results on the previously untouched data; this is standard practice. TABLE V. Margin Status by Age. Age, yr No. of Patients No. Positive Margins Percent Positive þ

4 The predictor variables were chosen based on a combination of previously published reports and clinical suspicion. It has been noted that MIS has an unusually high rate of positive histopathologic margin compared to invasive subtypes of melanoma. 9,10,22 Based on the high published rate of positive margins after resection of MIS and our clinical experience, we chose to look at the various melanoma subtypes including MIS as a predictor of positive margins. It was interesting to note that MIS failed to show a higher rate of positivity than invasive subtypes. As noted in the surgical technique section, planned margins for MIS resection were 5 mm, and based on published reports with this margin, the expected margin positivity rate would be 14% to 50% The 12% positive margin rate in 114 MIS patients is distinctly less than is often posited when taking 5-mm margins. The low positivity rate in the MIS group could be due to the slightly smaller lesion size in this sample ( mm in greatest diameter) compared to the >2-cm lesions in other studies. 10 However, that explanation assumes a higher positivity rate with larger lesions, which this study failed to prove. In addition, many of the studies quoting higher positivity rates (or larger than 5-mm margins needed for clearance) utilized Mohs technique to assess the entire margin periphery. 9,22,23 Margins for the lesions in this study were assessed by a combination of transverse vertical sectioning and en face margins, depending on the pathologist. Transverse vertical sections may not assess the entire margin periphery, resulting in an elevated false-negative rate. 24 To assess whether this is the case, we will need to examine longterm survival data including local recurrence from this data set. Regardless, using standard pathologic techniques, these data confirm the NCCN guidelines for 0.5- cm margins in resecting MIS. It has also been noted that DOI correlates with positive histopathologic margin when the same size margin is taken. 10,13 This clinical tenet has been the foundation for the various guidelines regarding surgical margins in resecting melanoma; the deeper the invasion, the larger the margin needed. The appropriate surgical margin for melanomas of various depths of invasion is an important clinical topic with a great deal of evidence behind the recommendations. 3,7,17,25 30 Those recommendations were inherently incorporated into this study as NCCN margin guidelines were followed at resection. Therefore, investigating whether DOI correlated with positive margin was essentially controlled for by taking the recommended larger margins for deeper tumors. The relatively constant margin positivity rate with increasing DOI and lack of DOI as a statistically significant predictor are therefore expected when all DOIs are studied in this data set. This result helps to verify the current NCCN recommendations. To study whether DOI correlates with margin positivity, each level of surgical margin would have to be studied separately (i.e., by evaluating margin positivity within intermediate-depth lesions excised with a 1- vs. 2-cm margin). This study does not have enough patients to perform such a risk adjustment. It has also been noted that lesion diameter correlates with positive margin. 10 Our data set did not reveal an increase in lesion diameter correlating with positive margin, although again this assessment would be even stronger if analysis could be risk adjusted by margin of resection. Clinical experience led us to study subsite of the head and neck as a possible predictor of positive margin, as scalp and forehead lesions seemed to have a higher rate of positive margin and need for re-excision. However, analysis of our data showed no statistical difference between subsites in terms of positive margin rate when analyzed using logistic regression. As a methods check, a simple contingency table was made to study the site with the highest positivity rate (forehead, 19%) compared to all the rest, and a Fischer exact test performed. We still failed to show a statistically significant difference, confirming the findings of the logistic regression that subsite does not predict positive margin after resection. Of the predictor variables studied, the least relevant variable from a clinical experience standpoint was patient age. However, the logistic regression analysis proved this to be the only significant predictor of margin positivity. The notable aspect of this conclusion is not an extremely high margin positivity rate in patients older than 75 years (15.6%þ), but the relatively low positivity rate in patients 55 and younger (4.6%). This rate of 4.6% in the youngest quartile of the data set is lower than the lowest rate cited by groups performing immediate reconstruction (6%). 13 One possible explanation for the finding that age is a statistically significant predictor of margin positivity is its role as a confounder for an unstudied variable. If age were studied alone, one would question if any noted correlation was possibly confounded by increasing tumor burden with age (increasing DOI or tumor diameter). However, those are controlled for by including them in the logistic regression. This can also be studied by looking at descriptive data by age as shown in Table VI. Note similarity of melanoma, except for a slightly larger diameter melanoma in the older patients (P ¼.05). Recall that tumor diameter, when tested independently, did not correlate with positive margin status. Something possibly not controlled for, yet inherently related to age, is the concept of multifocal disease; there is a higher likelihood of adjacent sun-damaged skin containing melanoma as the patient ages. Controlling for multifocal disease would be difficult unless it was routinely specified on the pathology report. Our pathology reports do not routinely note whether marginal disease was from a separate focus or extension of the same tumor. Therefore, we are left to view age as either a surrogate of an unknown confounder such as multifocal disease or a small but significant predictor of margin positivity. The data set had similar rates of overall positive margins when compared to the literature and similar distribution of tumor stages, tumor depths, and tumor size, indicating that the statistical conclusions from this study apply to the larger population. One aberrant characteristic of the data was the relatively low proportion of 686

5 TABLE VI. Dataset Description by Age. Age, yr No. of Patients DOI, mm* SD Size, mm SD Subtype No. (%) Location % < MIS 80 (26) Cheek 0.25 Invasive 226 (74) Ear 0.20 Scalp þ MIS 33 (32) Cheek 0.30 Invasive 69 (68) Ear 0.19 Scalp 0.13 *Independent samples t test, P ¼.430. Independent samples t test, P ¼.049. v 2 test of proportions for MIS, P ¼.131. v 2 test of proportions for location P ¼.502. DOI ¼ depth of invasion; MIS ¼ melanoma in situ; SD ¼ standard deviation. tumors that were MIS; a sample statistic of 28% compared with a parameter of 45% in the population. 10 This likely represents a slight selection bias for more invasive melanomas referred to the OTO-HNS department, compared to MIS, which is more commonly resected by the dermatologists in our region. However, given the similar positive margin rates compared with invasive melanomas, a larger MIS cohort would not change the conclusion. Had there been a distinct difference in positive margin rates between MIS and invasive melanomas, the smaller MIS cohort might have led to a type I error. In summary, the unexpected findings from this outcomes project were 1) age as a statistically significant predictor of margin positivity, with patients younger than 55 having a very low positivity rate, 2) the lack of higher margin positivity in MIS lesions, 3) the lack of higher positivity with larger diameter lesions, 4) the lack of higher margin positivity with any specific location on the head and neck, and 5) the similar rates of margin positivity with increasing DOI for invasive melanomas, confirming the NCCN resection guidelines. There must be a balance in resection of head and neck cutaneous melanoma. To clear 99% of tumors histopathologically, the initial margins would be 0.9 cm for MIS and larger for invasive disease. 9 This practice would incur a significant increase in functional and cosmetic disability in patients who would have had clear margins with smaller resection. Therefore, until a definitive Mohs-type technique that can be incorporated with sentinel node biopsy is developed, a certain low rate of margin positivity is acceptable. CONCLUSION In a logistic regression model of melanoma margins, increasing patient age renders the margins more likely to be positive after initial definitive resection. Melanoma subtype, DOI, location on the face, and lesion diameter do not have a statistically significant bearing on the likelihood of margin positivity. Resection of cutaneous head and neck melanoma remains fraught with a small, constant, and relatively unpredictable positive margin rate. This should lend caution to the surgeon performing an immediate, margin-compromising reconstruction. The surgeon should also be hesitant to compromise surgical margin width in older patients and should give consideration to more aggressive margins in hopes of performing a single resection. These results also prompt consideration of future evaluation of survival data in elderly melanoma patients. Although they may have higher rates of positive margin at the initial resection, we assume they ultimately achieve negative pathologic margin status by further resection. However, if the tumors in the elderly are more aggressive, it would show in evaluation of stage-matched disease-specific survival. Positive margin has been shown to correlate with local recurrence, which infers decreased survival. 6,31 The next feasible study from this data set will examine survival analysis as predicted by distance to clear histopathologic margin. This could help to provide data for histopathologic margins needed to survive melanoma, as current recommendations merely state clear is all that is needed. Acknowledgment The authors thank Dane Barrett, MD, for assistance with the data collection. BIBLIOGRAPHY 1. National Cancer Institute. SEER Stat Fact Sheets: Melanoma of the skin. Available at: Accessed March 25, Gomez-Rivera F, Santillan A, McMurphey AB, et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study. Head Neck 2008;30: Coit DG, Andtbacka R, Anker CJ, et al. Melanoma. J Natl Compr Canc Netw 2012;10: Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to J Am Acad Dermatol 2011;65:S78 S Blank CU, Hooijkaas AI, Haanen JB, Schumacher TN. Combination of targeted therapy and immunotherapy in melanoma. Cancer Immunol Immunother 2011;60: Erickson Foster J, Velasco JM, Hieken TJ. Adverse outcomes associated with noncompliance with melanoma treatment guidelines. Ann Surg Oncol 2008;15: Thomas JM, Newton-Bishop J, A Hern R, et al. Excision margins in highrisk malignant melanoma. N Engl J Med 2004;350: Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines J Am Acad Dermatol 2002;47: Kunishige JH, Brodland DG, Zitelli JA. Surgical margins for melanoma in situ. J Am Acad Dermatol 2012;66: Moller MG, Pappas-Politis E, Zager JS, et al. Surgical management of melanoma-in-situ using a staged marginal and central excision technique Ann Surg Oncol 2009;16:

6 11. Dengel L, Turza K, Noland MM, Patterson JW, Slingluff CLJr. Skin mapping with punch biopsies for defining margins in melanoma: when you don t know how far to go. Ann Surg Oncol 2008;15: Anderson KW, Baker SR, Lowe L, Su L, Johnson TM. Treatment of head and neck melanoma, lentigo maligna subtype: a practical surgical technique. Arch Facial Plast Surg 2001;3: Sullivan SR, Scott JR, Cole JK, et al. Head and neck malignant melanoma: margin status and immediate reconstruction. Ann Plast Surg 2009;62: Bogle M, Kelly P, Shenaq J, Friedman J, Evans GR. The role of soft tissue reconstruction after melanoma resection in the head and neck. Head Neck 2001;23: Sullivan SR, Liu DZ, Mathes DW, Isik FF. Head and neck malignant melanoma: local recurrence rate following wide local excision and immediate reconstruction. Ann Plast Surg 2012;68: Houghton A, Coit D, Bloomer W, et al. NCCN melanoma practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) 1998;12: Lens MB, Dawes M, Goodacre T, Bishop JA. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002;137: National Comprehensive Cancer Network Melanoma. Melanoma. Clinical practice guidelines in oncology J Natl Compr Canc Netw 2004;2: Houghton AN, Coit DG, Daud A, et al. Melanoma. J Natl Compr Canc Netw 2006;4: Coit DG, Andtbacka R, Bichakjian CK, et al. Melanoma. J Natl Compr Canc Netw 2009;7: Vittinghoff E, Glidden D, Shiboski S, McCulloch C, eds. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. New York, NY: Springer; Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma J Am Acad Dermatol 1997;37: Jejurikar SS, Borschel GH, Johnson TM, Lowe L, Brown DL. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control. Plast Reconstr Surg 2007;120: Trotter MJ. Melanoma margin assessment. Surgical Pathology Clinics 2009;2: Wong JY, Sondak VK. Unanswered questions about margin recommendations for primary cutaneous melanoma. J Natl Compr Canc Netw 2012; 10: Veronesi U, Cascinelli N, Adamus J, et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988;318: Sladden MJ, Balch C, Barzilai DA, et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009;(4): CD Balch CM, Soong SJ, Smith T, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 2001;8: Gillgren P, Drzewiecki KT, Niin M, et al. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet 2011;378: Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer 2003;97: McKinnon JG, Starritt EC, Scolyer RA, McCarthy WH, Thompson JF. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or ¼2 mm thick. Ann Surg 2005;241:

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media Melanoma and Dermoscopy Richard P. Usatine, MD, FAAFP Professor, Family and Community Medicine Professor, Dermatology and Cutaneous Surgery Medical Director, University Skin Clinic University of Texas

More information

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma Cutaneous Melanoma: Epidemiology (USA) 6 th leading cause of cancer among men and women 68,720 new cases of invasive melanoma in 2009 8,650 deaths from melanoma

More information

Melanoma Extirpation with Immediate Reconstruction: The Oncologic Safety and Cost Savings of Single-Stage Treatment.

Melanoma Extirpation with Immediate Reconstruction: The Oncologic Safety and Cost Savings of Single-Stage Treatment. RECONSTRUCTIVE Melanoma Extirpation with Immediate Reconstruction: The Oncologic Safety and Cost Savings of Single-Stage Treatment Irena Karanetz, M.D. Sharon Stanley, M.D. Denis Knobel, M.D. Benjamin

More information

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS

More information

Talk to Your Doctor. Fact Sheet

Talk to Your Doctor. Fact Sheet Talk to Your Doctor Hearing the words you have skin cancer is overwhelming and would leave anyone with a lot of questions. If you have been diagnosed with Stage I or II cutaneous melanoma with no apparent

More information

Advances in Surgical Management of Primary Melanoma: Identifying Patients Who Need More than Conventional Wide Local Excision

Advances in Surgical Management of Primary Melanoma: Identifying Patients Who Need More than Conventional Wide Local Excision Advances in Surgical Management of Primary Melanoma: Identifying Patients Who Need More than Conventional Wide Local Excision Christopher J. Miller, MD Director of Penn Dermatology Oncology Center Associate

More information

Sentinel Lymph Node Status is the Most Important Prognostic Factor in Patients With Melanoma of the Scalp

Sentinel Lymph Node Status is the Most Important Prognostic Factor in Patients With Melanoma of the Scalp The Laryngoscope VC 2013 The American Laryngological, Rhinological and Otological Society, Inc. Sentinel Lymph Node Status is the Most Important Prognostic Factor in Patients With Melanoma of the Scalp

More information

Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy

Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Dale Han, MD Assistant Professor Department of Surgery Section of Surgical Oncology No disclosures Background Desmoplastic melanoma (DM)

More information

Lentigo Maligna: Striking a Balance With the Risk-Benefit Ratio. Glen M. Bowen, MD Huntsman Cancer Institute University of Utah

Lentigo Maligna: Striking a Balance With the Risk-Benefit Ratio. Glen M. Bowen, MD Huntsman Cancer Institute University of Utah Lentigo Maligna: Striking a Balance With the Risk-Benefit Ratio Glen M. Bowen, MD Huntsman Cancer Institute University of Utah I. Objectives: a. Review the terminology of LM/LMM b. Understand the relative

More information

Skin lesions suspicious for melanoma: New Zealand excision margin guidelines in practice

Skin lesions suspicious for melanoma: New Zealand excision margin guidelines in practice Skin lesions suspicious for melanoma: excision margin guidelines in practice Tess Brian MBBS; 1 Michael B. Jameson MBChB, FRACP, FRCP, PhD 2,3 1 Department of Plastic and Reconstructive Surgery, Waikato

More information

ORIGINAL ARTICLE PROGNOSTIC IMPLICATION OF SENTINEL LYMPH NODE BIOPSY IN CUTANEOUS HEAD AND NECK MELANOMA

ORIGINAL ARTICLE PROGNOSTIC IMPLICATION OF SENTINEL LYMPH NODE BIOPSY IN CUTANEOUS HEAD AND NECK MELANOMA ORIGINAL ARTICLE PROGNOSTIC IMPLICATION OF SENTINEL LYMPH NODE BIOPSY IN CUTANEOUS HEAD AND NECK MELANOMA Benjamin E. Saltman, MD, 1 Ian Ganly, MD, 2 Snehal G. Patel, MD, 2 Daniel G. Coit, MD, 3 Mary Sue

More information

Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas

Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas 10 The Open Otorhinolaryngology Journal, 2011, 5, 10-14 Open Access Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas Kevin C. Huoh and Steven J. Wang * Head and Neck Surgery and Oncology,

More information

ORIGINAL ARTICLE. Clinical Node-Negative Thick Melanoma

ORIGINAL ARTICLE. Clinical Node-Negative Thick Melanoma ORIGINAL ARTICLE Clinical Node-Negative Thick Melanoma George I. Salti, MD; Ashwin Kansagra, MD; Michael A. Warso, MD; Salve G. Ronan, MD ; Tapas K. Das Gupta, MD, PhD, DSc Background: Patients with T4

More information

INTRODUCTION. Abbreviations used: ALM: acral lentiginous melanoma LM: lentigo maligna MM: melanoma MMS: Mohs micrographic surgery SS: staged surgery

INTRODUCTION. Abbreviations used: ALM: acral lentiginous melanoma LM: lentigo maligna MM: melanoma MMS: Mohs micrographic surgery SS: staged surgery The spaghetti technique : An alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma) Caroline Gaudy-Marqueste, MD, PhD, a Anne-Sophie

More information

Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy

Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy American Academy of Dermatology 2018 Annual Meeting San Diego, CA, February 17, 2018 Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy Christopher Bichakjian,

More information

Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases

Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases Faruk Tas, Sidika Kurul, Hakan Camlica and Erkan Topuz Institute of Oncology, Istanbul University, Istanbul, Turkey Received

More information

Melanoma Surgery Update James R. Ouellette, DO FACS Premier Health Cancer Institute Wright State University Chief, Surgical Oncology Division

Melanoma Surgery Update James R. Ouellette, DO FACS Premier Health Cancer Institute Wright State University Chief, Surgical Oncology Division Melanoma Surgery Update 2018 James R. Ouellette, DO FACS Premier Health Cancer Institute Wright State University Chief, Surgical Oncology Division Surgery for Melanoma Mainstay of treatment for potentially

More information

Rebecca Vogel, PGY-4 March 5, 2012

Rebecca Vogel, PGY-4 March 5, 2012 Rebecca Vogel, PGY-4 March 5, 2012 Historical Perspective Changes In The Staging System Studies That Started The Talk Where We Go From Here Cutaneous melanoma has become an increasingly growing problem,

More information

Dr. Brent Doolan, BSc MBBS MPH

Dr. Brent Doolan, BSc MBBS MPH Impact of partial biopsies on the need for complete excisional surgery in the management of cutaneous melanomas: A multi-centre review Dr. Brent Doolan, BSc MBBS MPH Peter MacCallum Cancer Centre, Melbourne

More information

Disclosures. SLNB for Melanoma 25/02/2014 SENTINEL LYMPH NODE BIOPSY FOR MELANOMA: CURRENT GUIDELINES AND THEIR CLINICAL APPLICATION

Disclosures. SLNB for Melanoma 25/02/2014 SENTINEL LYMPH NODE BIOPSY FOR MELANOMA: CURRENT GUIDELINES AND THEIR CLINICAL APPLICATION 8 th Canadian Melanoma Conference February 22, 2014 Rimrock Resort Hotel, Banff, Alberta SENTINEL LYMPH NODE BIOPSY FOR MELANOMA: CURRENT GUIDELINES AND THEIR CLINICAL APPLICATION Christopher Bichakjian,

More information

Clinico-pathological Features of Patients with Melanoma and Positive Sentinel Lymph Node Biopsy: A Single Institution Experience

Clinico-pathological Features of Patients with Melanoma and Positive Sentinel Lymph Node Biopsy: A Single Institution Experience 2015;23(2):122-129 CLINICAL ARTICLE Clinico-pathological Features of Patients with Melanoma and Positive Sentinel Lymph Node Biopsy: A Single Institution Experience Damir Homolak 1, Mirna Šitum 2,3, Hrvoje

More information

ELIZABETH CEDARS DR. KOREY HOOD Available September 29

ELIZABETH CEDARS DR. KOREY HOOD Available September 29 ELIZABETH CEDARS DR. KOREY HOOD Available September 29 Title and Investigators Optimizing Surgical Management of Thyroid Cancer: Using Surgeon-performed Ultrasound to Predict Extrathyroidal Extension of

More information

Protocol applies to melanoma of cutaneous surfaces only.

Protocol applies to melanoma of cutaneous surfaces only. Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC

More information

Surgical Issues in Melanoma

Surgical Issues in Melanoma Surgical Issues in Melanoma Mark B. Faries, MD, FACS Director, Donald L. Morton Melanoma Research Program Director, Surgical Oncology Training Program Professor of Surgery John Wayne Cancer Institute Surgical

More information

Epithelial Cancer- NMSC & Melanoma

Epithelial Cancer- NMSC & Melanoma Epithelial Cancer- NMSC & Melanoma David Chin MB, BCh, BAO, LRCP, LRCS (Ireland) MCh(MD), PhD (UQ), FRCS, FRACS (Plast) Plastic & Reconstructive Surgeon Visiting Scientist Melanoma Genomic Group & Drug

More information

Characteristics and Treatment of Cutaneous Melanoma of the Foot

Characteristics and Treatment of Cutaneous Melanoma of the Foot Characteristics and Treatment of Cutaneous Melanoma of the Foot Kyung Wook Nam, Yong Chan Bae,, Soo Bong Nam, Joo Hyung Kim, Hoon Soo Kim, Young Jin Choi Department of Plastic and Reconstructive Surgery,

More information

Index. Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, Anorectal melanoma RT for, 1035

Index. Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, Anorectal melanoma RT for, 1035 Index Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, 947 948 Anorectal melanoma RT for, 1035 B Bacille Calmette-Guerin (BCG) in melanoma, 1008 BCG. See Bacille

More information

Interesting Case Series. Aggressive Tumor of the Midface

Interesting Case Series. Aggressive Tumor of the Midface Interesting Case Series Aggressive Tumor of the Midface Adrian Frunza, MD, Dragos Slavescu, MD, and Ioan Lascar, MD, PhD Bucharest Emergency Clinical Hospital, Bucharest University School of Medicine,

More information

MING H. JIH, MD,PHD, PAUL M. FRIEDMAN, MD,LEONARD H. GOLDBERG, MD,AND ARASH KIMYAI-ASADI, MD. Methods Phase I: Retrospective (Group 1)

MING H. JIH, MD,PHD, PAUL M. FRIEDMAN, MD,LEONARD H. GOLDBERG, MD,AND ARASH KIMYAI-ASADI, MD. Methods Phase I: Retrospective (Group 1) Curettage prior to Mohs Micrographic Surgery for Previously Biopsied Nonmelanoma Skin Cancers: What Are We Curetting? Retrospective, Prospective, and Comparative Study MING H. JIH, MD,PHD, PAUL M. FRIEDMAN,

More information

Proposal for a 2-stage RCT in high risk primary SCC: COMMISSAR Catherine Harwood Barts Health NHS Trust / QMUL

Proposal for a 2-stage RCT in high risk primary SCC: COMMISSAR Catherine Harwood Barts Health NHS Trust / QMUL Proposal for a 2-stage RCT in high risk primary SCC: COMMISSAR Catherine Harwood Barts Health NHS Trust / QMUL on behalf of Dr Louise Lansbury, Prof Fiona Bath-Hextall Nottingham Centre for Evidence Based

More information

1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.

1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter. Skin Cancer follow up guidelines If NEW serious diagnosis given: 1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter. 2. Free prescription information details. 3.

More information

Contrast with Australian Guidelines A/Pr Pascale Guitera,

Contrast with Australian Guidelines A/Pr Pascale Guitera, Contrast with Australian Guidelines A/Pr Pascale Guitera, Dermatologist, Sydney University NO CONFLICT OF INTEREST Sydney Melanoma Diagnostic Centre, RPAH 2011 2008 225 pages 16 pages http://www.cancer.org.au/file/healthprofessionals/clinica

More information

5/20/2015. Mohs Surgery BCCA High risk anatomic locations. Mohs Surgery High risk anatomic locations. Mohs Surgery Histologically Aggressive BCCA

5/20/2015. Mohs Surgery BCCA High risk anatomic locations. Mohs Surgery High risk anatomic locations. Mohs Surgery Histologically Aggressive BCCA Mohs Surgery BCCA High risk anatomic locations High risk areas H zone nasal ala, nasal septum, nasal ala groove, periorbital region, periauricual region, region around and in ear canal, ear pinna and scalp

More information

Katsuhiro Yamada, Natsuko Noguti, Masaaki Tsuda, Hazime Nagato, Naoko Hasunuma, Yoshihiro Umebayashi and Motomu Manabe

Katsuhiro Yamada, Natsuko Noguti, Masaaki Tsuda, Hazime Nagato, Naoko Hasunuma, Yoshihiro Umebayashi and Motomu Manabe Akita J Med 36 : 45-52, 2009 45 Katsuhiro Yamada, Natsuko Noguti, Masaaki Tsuda, Hazime Nagato, Naoko Hasunuma, Yoshihiro Umebayashi and Motomu Manabe (Received 22 December 2008, Accepted 15 January 2009)

More information

Desmoplastic Melanoma: Clinical Behavior and Management Implications

Desmoplastic Melanoma: Clinical Behavior and Management Implications Desmoplastic Melanoma: Clinical Behavior and Management Implications Collier S. Pace, MD, a Jyoti P. Kapil, MD, b Luke G. Wolfe, MS, c Brian J. Kaplan, MD, c and James P. Neifeld, MD c a Division of Plastic

More information

Pearls for Keeping it Simple in Cutaneous Reconstruction

Pearls for Keeping it Simple in Cutaneous Reconstruction Pearls for Keeping it Simple in Cutaneous Reconstruction Jerry D. Brewer, MD, MS, FAAD brewer.jerry@mayo.edu Professor of Dermatology Division of Dermatologic Surgery Department of Dermatology Mayo Clinic

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our

More information

Surgical treatment of non-melanoma skin cancer of the head and neck: expanding reconstructive options van der Eerden, P.A.

Surgical treatment of non-melanoma skin cancer of the head and neck: expanding reconstructive options van der Eerden, P.A. UvA-DARE (Digital Academic Repository) Surgical treatment of non-melanoma skin cancer of the head and neck: expanding reconstructive options van der Eerden, P.A. Link to publication Citation for published

More information

Technicians & Nurses Program

Technicians & Nurses Program ASCRS ASOA Symposium & Congress Technicians & Nurses Program May 6-10, 2016 New Orleans Evaluation and Treatment of Eyelid Malignancies Richard C. Allen MD PhD FACS Professor Section of Ophthalmology Dept.

More information

You Are Going to Cut How Much Skin? Locoregional Surgical Treatment. Justin Rivard MD, MSc, FRCSC September 21, 2018

You Are Going to Cut How Much Skin? Locoregional Surgical Treatment. Justin Rivard MD, MSc, FRCSC September 21, 2018 You Are Going to Cut How Much Skin? Locoregional Surgical Treatment Justin Rivard MD, MSc, FRCSC September 21, 2018 Presenter Disclosure Faculty/Speaker: Justin Rivard Relationships with financial sponsors:

More information

World Articles of Ear, Nose and Throat Page 1

World Articles of Ear, Nose and Throat Page 1 World Articles of Ear, Nose and Throat ---------------------Page 1 Primary Malignant Melanoma of the Tongue: A Case Report Authors: Nanayakkara PR*, Arudchelvam JD** Ariyaratne JC*, Mendis K*, Jayasekera

More information

1

1 www.clinicaloncology.com.ua 1 Prognostic factors of appearing micrometastases in sentinel lymph nodes in skin melanoma M.N.Kukushkina, S.I.Korovin, O.I.Solodyannikova, G.G.Sukach, A.Yu.Palivets, A.N.Potorocha,

More information

For additional information on meeting the criteria for Mohs, see Appendix 2.

For additional information on meeting the criteria for Mohs, see Appendix 2. Position Statement on Appropriate Uses of Paraffin Sections in Association (Approved by the Board of Directors: August 1, 2011; Revised November 5, 2011; Revised August 9, 2014) According to AMA/CPT, Mohs

More information

Practical Tips for Caring for Melanoma Patients

Practical Tips for Caring for Melanoma Patients Practical Tips for Caring for Melanoma Patients Caroline C. Kim, MD, Director Assistant Professor, Department of Dermatology Harvard Medical School Director, Pigmented Lesion Clinic Associate Director,

More information

Does the Type of Cleft Palate Contribute to the Need for Secondary Surgery? A National Perspective

Does the Type of Cleft Palate Contribute to the Need for Secondary Surgery? A National Perspective The Laryngoscope VC 2013 The American Laryngological, Rhinological and Otological Society, Inc. Does the Type of Cleft Palate Contribute to the Need for Secondary Surgery? A National Perspective James

More information

Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]

Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ] CS Tumor Size Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ] Note: the specific tumor size as documented in the medical record. If the ONLY information regarding tumor size is the physician's

More information

Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact

Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most

More information

Skin Cancer of the Nose: Common and Uncommon

Skin Cancer of the Nose: Common and Uncommon Skin Cancer of the Nose: Common and Uncommon Mark Russell, M.D. Associate Professor of Dermatology, Otolaryngology, and Pathology University of Virginia Objectives Review clinical presentations of select

More information

Key words: scar/had/pais-sr/mos-sf36 J Investig Dermatol Symp Proc 9: , 2004

Key words: scar/had/pais-sr/mos-sf36 J Investig Dermatol Symp Proc 9: , 2004 A Quality-of-Life Study in High-Risk (Thickness X 2 mm) Cutaneous Melanoma Patients in a Randomized Trial of 1-cm versus 3-cm Surgical Excision Margins Julia A. Newton-Bishop, Clarissa Nolan, Faye Turner,

More information

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma Common Medicolegal Situations: Misdiagnosis of Melanoma David B. Troxel, MD Medical Director, The Doctors Company, Napa, California Clinical Professor Emeritus, University of California at Berkeley Past

More information

JAM ACAD DERMATOL VOLUME 76, NUMBER 2. Research Letters 351

JAM ACAD DERMATOL VOLUME 76, NUMBER 2. Research Letters 351 JAM ACAD DERMATOL Research Letters 351 Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes To the Editor:

More information

LENTIGO MALIGNA (LM) IS A

LENTIGO MALIGNA (LM) IS A STUDY Geometric Staged Excision for the Treatment of Lentigo Maligna and Lentigo Maligna Melanoma A Long-term Experience With Literature Review Mark Abdelmalek, MD; Michael P. Loosemore, MD; Mark A. Hurt,

More information

Ethnic disparities in melanoma diagnosis and survival

Ethnic disparities in melanoma diagnosis and survival Ethnic disparities in melanoma diagnosis and survival The effects of socioeconomic status and health insurance coverage Amy M. Anderson-Mellies, MPH 1 Matthew J. Rioth, MD 1,2,3 Myles G. Cockburn, PhD

More information

Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma

Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma A. J. Page, Emory University A. Li, Emory University

More information

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type Primary Cutaneous Melanoma Pathology Reporting Proforma Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth DD MM YYYY Sex Male Female

More information

I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee

I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee Some thoughts Is this skin cancer? How common is this? How likely is this in this patient? What happens next if it s something

More information

ORIGINAL ARTICLE. Regional Lymph Node Metastasis From Cutaneous Squamous Cell Carcinoma

ORIGINAL ARTICLE. Regional Lymph Node Metastasis From Cutaneous Squamous Cell Carcinoma ORIGINAL ARTICLE Regional Lymph Node Metastasis From Cutaneous Squamous Cell Carcinoma Dennis H. Kraus, MD; John F. Carew, MD; Louis B. Harrison, MD Objective: To characterize clinical presentation and

More information

Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment

Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment Makenzie L. Hawkins, MSPH 1 Matthew J. Rioth, MD 1,2 Megan M. Eguchi, MPH 1 Myles Cockburn, Phd

More information

LYMPHATIC DRAINAGE PATTERNS OF HEAD AND NECK CUTANEOUS MELANOMA OBSERVED ON LYMPHOSCINTIGRAPHY AND SENTINEL LYMPH NODE BIOPSY

LYMPHATIC DRAINAGE PATTERNS OF HEAD AND NECK CUTANEOUS MELANOMA OBSERVED ON LYMPHOSCINTIGRAPHY AND SENTINEL LYMPH NODE BIOPSY LYMPHATIC DRAINAGE PATTERNS OF HEAD AND NECK CUTANEOUS MELANOMA OBSERVED ON LYMPHOSCINTIGRAPHY AND SENTINEL LYMPH NODE BIOPSY Doris Lin, MD, 1 Benjamin L. Franc, MD, 2 Mohammed Kashani-Sabet, MD, 3 Mark

More information

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD Melanoma Kaushik Mukherjee MD A. Scott Pearson MD Disclosures You still have to study Not all inclusive No Western blots Extensive use of Google Image Search and Sabiston Melanoma Basics 8 th most common

More information

Interesting Case Series. Desmoplastic Melanoma

Interesting Case Series. Desmoplastic Melanoma Interesting Case Series Desmoplastic Melanoma Anthony Maurice Kordahi, MD, Joshua B. Elston, MD, Ellen M. Robertson, MD, and C. Wayne Cruse, MD Division of Plastic Surgery, Department of Surgery, University

More information

MOHS MICROGRAPHIC SURGERY: AN OVERVIEW

MOHS MICROGRAPHIC SURGERY: AN OVERVIEW MOHS MICROGRAPHIC SURGERY: AN OVERVIEW SKIN CANCER: Skin cancer is far and away the most common malignant tumor found in humans. The most frequent types of skin cancer are basal cell carcinoma, squamous

More information

Section 1: Personal information

Section 1: Personal information A survey on the use of ultrasound examination of the regional lymph nodes in the follow up of patients with high-risk cutaneous squamous cells carcinomas (SCCs). Note: In the definition of cutaneous squamous

More information

Updates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD

Updates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD Updates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD Disclosure Statement Update on Melanoma Are You Following the Latest Guidelines of Care? I, Jerry D. Brewer, MD, do

More information

Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG

Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG At tumor board, a surgeon insists that all level II melanomas are invasive since they have broken through the

More information

Surgical Margins in Cutaneous Melanoma (2 cm Versus 5 cm for Lesions Measuring Less Than 2.1-mm Thick)

Surgical Margins in Cutaneous Melanoma (2 cm Versus 5 cm for Lesions Measuring Less Than 2.1-mm Thick) 1941 Surgical Margins in Cutaneous Melanoma (2 cm Versus 5 cm for Lesions Measuring Less Than 2.1-mm Thick) Long-Term Results of a Large European Multicentric Phase III Study David Khayat, M.D., Ph.D.

More information

Kevin T. Kavanagh, MD

Kevin T. Kavanagh, MD Kevin T. Kavanagh, MD Axial Based upon a named artery. Survival length depends upon the artery not the width of the flap. Random Has random unnamed vessels supplying it. Survival length is directly proportional

More information

SKIN CANCER. Most common cancer diagnosis 40% of all cancers

SKIN CANCER. Most common cancer diagnosis 40% of all cancers SKIN CANCER Most common cancer diagnosis 40% of all cancers OBJECTIVES Review common and uncommon cancers of the skin. Special emphasis on melanoma and dysplastic nevus Review pathology/tnm/staging, which

More information

Radiation (ebt/hdr) for Non-Melanoma Skin Cancers (NMSCC) in the Dermatologist s Office: A Radiation Oncologist s (Generally Positive) Perspective

Radiation (ebt/hdr) for Non-Melanoma Skin Cancers (NMSCC) in the Dermatologist s Office: A Radiation Oncologist s (Generally Positive) Perspective Radiation (ebt/hdr) for Non-Melanoma Skin Cancers (NMSCC) in the Dermatologist s Office: A Radiation Oncologist s (Generally Positive) Perspective Mohammad K Khan MD Ph.D FACRO Associate Professor Director,

More information

Collaborative Staging Manual and Coding Instructions Part II: Primary Site Schema

Collaborative Staging Manual and Coding Instructions Part II: Primary Site Schema C44.0-C44.9, C51.0-C51.2, C51.8-C51.9, C60.0-C60.2, C60.8-C60.9, C63.2 (M-8720-8790) C44.0 Skin of lip, NOS C44.1 Eyelid C44.2 External ear C44.3 Skin of ear and unspecified parts of face C44.4 Skin of

More information

University of Groningen

University of Groningen University of Groningen Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients Faut, Marloes; Wevers, Kevin; van

More information

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine Glenn D. Goldman, MD Fletcher Allen Health Care University of Vermont College of Medicine Recognize and identify the main types of skin cancer Understand how and why Mohs surgery is utilized for the treatment

More information

Prognostic Variables and Surgical Management of Foot Melanoma: Review of a 25-Year Institutional Experience

Prognostic Variables and Surgical Management of Foot Melanoma: Review of a 25-Year Institutional Experience Virginia Commonwealth University VCU Scholars Compass Surgery Publications Dept. of Surgery 11 Prognostic Variables and Surgical Management of Foot Melanoma: Review of a 5-Year Institutional Experience

More information

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine Glenn D. Goldman, MD University of Vermont Medical Center University of Vermont College of Medicine Recognize and identify the main types of skin cancer and their precursors Identify and understand new

More information

American Head and Neck Society - Journal Club Volume 22, July 2018

American Head and Neck Society - Journal Club Volume 22, July 2018 - Table of Contents click the page number to go to the summary and full article link. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated

More information

Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy

Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy ORIGINAL ARTICLE Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy Melinda V. Davis Malesevich, MD, 1 Ryan Goepfert, MD, 2 Mark Kubik, MD, 1 Dianna B. Roberts,

More information

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Concise Reference Staging and Diagnosing Cutaneous Melanoma Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Extracted from Handbook of Cutaneous Melanoma: A Guide to Diagnosis and Treatment Published

More information

Melanoma Quality Reporting

Melanoma Quality Reporting Melanoma Quality Reporting September 1, 2013 December 31, 2016 Laurence McCahill, MD Surgical Oncologist Metro Health Surgical Oncology Metro Health Professional Building 2122 Health Drive SW Wyoming,

More information

Policy #: 127 Latest Review Date: June 2011

Policy #: 127 Latest Review Date: June 2011 Name of Policy: Mohs Micrographic Surgery Policy #: 127 Latest Review Date: June 2011 Category: Surgery Policy Grade: Active Policy but no longer scheduled for regular literature reviews and updates. Background/Definitions:

More information

This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper:

This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper: This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/127789/ Version: Accepted Version Article: Muinonen-Martin,

More information

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:

More information

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior

More information

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:

More information

ONCOLOGY DERMATOLOGY AND SURGERY Dr. Pedro Redondo

ONCOLOGY DERMATOLOGY AND SURGERY Dr. Pedro Redondo ONCOLOGY DERMATOLOGY AND SURGERY Dr. Pedro Redondo Mohs surgery limitations in large tumors Extension to the bone Tumor characteristics (desmoplastic) Agressive tumors Cutting related problems Wrinkles

More information

Clinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 124 Japanese Patients

Clinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 124 Japanese Patients Clinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 24 Japanese Patients Yoshie Kuno, Kazuyuki Ishihara, Naoya Yamazaki and Kiyoshi Mukai 2 'Dermatology Division

More information

Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction

Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction Aldona J. Spiegel, M.D., and Charles E. Butler, M.D. Houston, Texas Skin-sparing

More information

Primary Excision Margins and Sentinel Lymph Node Biopsy in Cutaneous Melanoma

Primary Excision Margins and Sentinel Lymph Node Biopsy in Cutaneous Melanoma A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Primary Excision Margins and Sentinel Lymph Node Biopsy in Cutaneous Melanoma F. Wright, L.H. Souter, S. Kellett,

More information

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL OBJECTIVES Discuss current trends and changing concepts in our understanding of

More information

Interesting Case Series. Reconstruction of Dorsal Wrist Defects

Interesting Case Series. Reconstruction of Dorsal Wrist Defects Interesting Case Series Reconstruction of Dorsal Wrist Defects Maelee Yang, BS, and Joseph Meyerson, MD The Ohio State University Wexner Medical Center, Columbus Correspondence: maelee.yang@osumc.edu Keywords:

More information

Basic Standards for Fellowship Training in Mohs Micrographic Surgery

Basic Standards for Fellowship Training in Mohs Micrographic Surgery Basic Standards for Fellowship Training in Mohs Micrographic Surgery American Osteopathic Association and American Osteopathic College of Dermatologists September, 1992 BOT/93 BOT 7/2011, Eff. 7/2012 Basic

More information

Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure

Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure Meg Watson, MPH Epidemiologist NAACCR Annual Conference June 16, 2016 National Center for Chronic Disease

More information

What is an Adequate Lumpectomy Margin in 2018?

What is an Adequate Lumpectomy Margin in 2018? What is an Adequate Lumpectomy Margin in 2018? Stuart J. Schnitt, M.D. Brigham and Women s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School Boston, MA None Disclosures Topics Current

More information

Regeneron and Sanofi are financial supporters of The Skin Cancer Foundation and collaborated in the development of this article. US-ONC /2018

Regeneron and Sanofi are financial supporters of The Skin Cancer Foundation and collaborated in the development of this article. US-ONC /2018 A D E E P E R L O O K When detected early, most cases of local cutaneous squamous cell carcinoma are easily treated and usually cured. But when they become more advanced, this second most common form of

More information

12. Malignant Melanoma of Skin

12. Malignant Melanoma of Skin KEY FACTS 12. Malignant Melanoma of Skin ICD-9 172 On average 160 melanomas of the skin were registered per year. Twice as common in females than in males. Higher than expected numbers in Southern Board

More information

Audit. Public Health Monitoring Report on 2006 Data. National Breast & Ovarian Cancer Centre and Royal Australasian College of Surgeons.

Audit. Public Health Monitoring Report on 2006 Data. National Breast & Ovarian Cancer Centre and Royal Australasian College of Surgeons. National Breast & Ovarian Cancer Centre and Royal Australasian College of Surgeons Audit Public Health Monitoring Report on 2006 Data November 2009 Prepared by: Australian Safety & Efficacy Register of

More information

CURRENT ISSUES IN TRANSPLANT DERMATOLOGY

CURRENT ISSUES IN TRANSPLANT DERMATOLOGY CURRENT ISSUES IN TRANSPLANT DERMATOLOGY NO CONFLICTS OF INTEREST TO DISCLOSE SOLID ORGAN TRANSPLANTATION: 2015 As of April 10, 2015.. 123,319 patients waiting for an organ transplant 2,557 performed this

More information

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center An Overview of Melanoma Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center Melanoma Statistics Median age at presentation 45-55 55 years Incidence: 2003 54,200 cases

More information

Clinical Case Conference Melanoma

Clinical Case Conference Melanoma Clinical Case Conference Melanoma Epidemiology ~60,000 cases and 8,000 deaths per year in US Caucasian:African American = 10:1 15% arise from existing nevi 91% are cutaneous 15% are LN+ at presentation

More information

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015 Breast Surgery When Less is More and More is Less E MacIntosh, MD June 6, 2015 Presenter Disclosure Faculty: E. MacIntosh Relationships with commercial interests: None Mitigating Potential Bias Not applicable

More information